Tandem Diabetes Care (TNDM) Inventory (2013 - 2026)

Tandem Diabetes Care has reported Inventory for 14 years, with the latest figure at $126.4 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory fell 10.46% year-over-year to $126.4 million; the trailing twelve-month figure through Mar 2026 stood at $126.4 million (down 10.46% YoY), and the FY2025 full-year result was $128.8 million, down 13.93% from the prior year.
• Inventory for Q1 2026 stood at $126.4 million, down from $128.8 million in the prior quarter.
• The five-year high for Inventory was $161.7 million in Q2 2024, with the low at $80.0 million in Q1 2022.
• Historically, Inventory has averaged $132.8 million across 5 years, with a median of $141.2 million in 2025.
• Annual changes were most pronounced in 2023 — Inventory jumped 67.54% — and 2025, when it decreased 13.93%.
• Tandem Diabetes Care's Inventory stood at $111.1 million in 2022, then soared by 42.14% to $157.9 million in 2023, then slipped by 5.27% to $149.6 million in 2024, then decreased by 13.93% to $128.8 million in 2025, then dropped by 1.84% to $126.4 million in 2026.
• The last three Inventory figures came in at $126.4 million (Q1 2026), $128.8 million (Q4 2025), and $137.3 million (Q3 2025), per Business Quant data.